Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Bashashati

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
The Journal of Pathology. Clinical Research|January 11, 2021
Adult-type granulosa cell tumor of the ovary: a FOXL2-centric diseaseJessica A Pilsworth, Dawn R Cochrane, Samantha J Neilson, et al.
Gastroenterology|May 13, 2019
Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to HypoxiaPaul C McDonald, Shawn C Chafe, Wells S Brown, et al.
Journal of the National Cancer Institute|February 3, 2016
Synchronous Endometrial and Ovarian Carcinomas: Evidence of ClonalityMichael S Anglesio, Yi Kan Wang, Madlen Maassen, et al.
Blood|March 30, 2017
Genetic profiling of <i>MYC</i> and <i>BCL2</i> in diffuse large B-cell lymphoma determines cell-of-origin-specific clinical impactDaisuke Ennishi, Anja Mottok, Susana Ben-Neriah, et al.
Blood|November 15, 2014
An RCOR1 loss-associated gene expression signature identifies a prognostically significant DLBCL subgroupFong Chun Chan, Adele Telenius, Shannon Healy, et al.
The Journal of Pathology|June 20, 2013
Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profilingAli Bashashati, Gavin Ha, Alicia Tone, et al.
The Journal of Pathology|July 21, 2020
Synthesis of diagnostic quality cancer pathology images by generative adversarial networksAdrian B Levine, Jason Peng, David Farnell, et al.
Cancer Discovery|February 2, 2019
Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune RecognitionDaisuke Ennishi, Katsuyoshi Takata, Wendy Béguelin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 4, 2018
Correction: TERT promoter mutation in adult granulosa cell tumor of the ovaryJessica A Pilsworth, Dawn R Cochrane, Zhouchunyang Xia, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 17, 2018
TERT promoter mutation in adult granulosa cell tumor of the ovaryJessica A Pilsworth, Dawn R Cochrane, Zhouchunyang Xia, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
The Journal of Pathology. Clinical Research|January 11, 2021
Adult-type granulosa cell tumor of the ovary: a FOXL2-centric diseaseJessica A Pilsworth, Dawn R Cochrane, Samantha J Neilson, et al.
Gastroenterology|May 13, 2019
Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to HypoxiaPaul C McDonald, Shawn C Chafe, Wells S Brown, et al.
Journal of the National Cancer Institute|February 3, 2016
Synchronous Endometrial and Ovarian Carcinomas: Evidence of ClonalityMichael S Anglesio, Yi Kan Wang, Madlen Maassen, et al.
Blood|March 30, 2017
Genetic profiling of <i>MYC</i> and <i>BCL2</i> in diffuse large B-cell lymphoma determines cell-of-origin-specific clinical impactDaisuke Ennishi, Anja Mottok, Susana Ben-Neriah, et al.
Blood|November 15, 2014
An RCOR1 loss-associated gene expression signature identifies a prognostically significant DLBCL subgroupFong Chun Chan, Adele Telenius, Shannon Healy, et al.
The Journal of Pathology|June 20, 2013
Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profilingAli Bashashati, Gavin Ha, Alicia Tone, et al.
The Journal of Pathology|July 21, 2020
Synthesis of diagnostic quality cancer pathology images by generative adversarial networksAdrian B Levine, Jason Peng, David Farnell, et al.
Cancer Discovery|February 2, 2019
Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune RecognitionDaisuke Ennishi, Katsuyoshi Takata, Wendy Béguelin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 4, 2018
Correction: TERT promoter mutation in adult granulosa cell tumor of the ovaryJessica A Pilsworth, Dawn R Cochrane, Zhouchunyang Xia, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 17, 2018
TERT promoter mutation in adult granulosa cell tumor of the ovaryJessica A Pilsworth, Dawn R Cochrane, Zhouchunyang Xia, et al.
Pageof 9